Zhao Junjie, Ye Junnan
Emergency and Critical Care Center, Department of Emergency Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, 310014, People's Republic of China.
Department of Emergency, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, 324000, People's Republic of China.
Infect Drug Resist. 2025 Sep 3;18:4659-4665. doi: 10.2147/IDR.S550784. eCollection 2025.
Severe community-acquired pneumonia (SCAP) in immunocompromised patients is often caused by rare atypical pathogens, which are difficult to detect using conventional microbiological tests (CMTs) and can progress to sepsis in severe cases. Metagenomic next-generation sequencing (mNGS), an emerging pathogen detection technique, enables rapid identification of mixed infections and provides valuable guidance for clinical treatment decisions. SCAP-induced sepsis caused by a six-pathogen co-infection has not been previously reported, but interpretation remains a challenge.
This report describes a case of SCAP-induced sepsis detected six pathogens by mNGS in a patient with IgA nephropathy who developed immunosuppression following long-term treatment with rituximab and corticosteroids. Bronchoalveolar lavage fluid (BALF) mNGS detected six pathogens, including , Primate bocaparvovirus 1, Cytomegalovirus, , and . The patient was admitted to the intensive care unit (ICU) and received a combination of meropenem, trimethoprim-sulfamethoxazole, ganciclovir, piperacillin-tazobactam, and caspofungin. Following appropriate treatment, the patient recovered and was successfully discharged.
mNGS offers significant advantages for the diagnosis and identification of mixed infections in immunocompromised patients with SCAP-induced sepsis. It enables clinicians to initiate timely and targeted antimicrobial therapy, which facilitates early recovery, reduces the overuse of broad-spectrum antibiotics, and ultimately improves patient prognosis. Nevertheless, its interpretation requires caution, as distinguishing true pathogens from colonizers or contaminants still relies on clinical correlation and complementary diagnostic methods.
免疫功能低下患者的重症社区获得性肺炎(SCAP)通常由罕见的非典型病原体引起,使用传统微生物检测(CMT)难以检测到,严重时可进展为脓毒症。宏基因组下一代测序(mNGS)是一种新兴的病原体检测技术,能够快速识别混合感染,并为临床治疗决策提供有价值的指导。此前尚未报道过由六种病原体共同感染引起的SCAP所致脓毒症,但解读仍是一项挑战。
本报告描述了一例IgA肾病患者在接受利妥昔单抗和皮质类固醇长期治疗后出现免疫抑制,通过mNGS检测出六种病原体的SCAP所致脓毒症病例。支气管肺泡灌洗液(BALF)mNGS检测到六种病原体,包括灵长类细小病毒1、巨细胞病毒等。患者被收入重症监护病房(ICU),接受了美罗培南、甲氧苄啶-磺胺甲恶唑、更昔洛韦、哌拉西林-他唑巴坦和卡泊芬净联合治疗。经过适当治疗,患者康复并成功出院。
mNGS在诊断和识别免疫功能低下的SCAP所致脓毒症患者的混合感染方面具有显著优势。它使临床医生能够及时启动有针对性的抗菌治疗,促进早期康复,减少广谱抗生素的过度使用,并最终改善患者预后。然而,其解读需要谨慎,因为区分真正的病原体与定植菌或污染物仍依赖于临床相关性和补充诊断方法。